Diagnosis Of Prostate Cancer ( Pca ) From Prevention, Pathology, And Treatment
1503 WordsNov 13, 20167 Pages
This report provides a holistic scope of prostate cancer (PCa) from prevention, pathology, diagnostic screening, pharmacology, and treatment methods. It also incorporates statistical data, and provides a case study that helps the prospective nursing student to analyze its implications for their practice. The current methods for PCa diagnostics is often times not conclusive, and this causes a controversial decision to be made by the patient and the healthcare provider to either perform a surgery to remove the prostate, or a wait-and-see method of progression. The gold standard for diagnostic screening for PCa has long been prostate specific antigen (PSA); however newer methods are coming to light that enhance the PCA screening by adding additional biomarkers and advanced algorithms that help to reduce over-diagnosis of PCa. The bright side to this disease is two-fold: it mainly effects those in older age, and early detection can account for a 95% success rate up to 15 years after detection.
Prostate Cancer: From Prevention to Treatment PCa is a disease that effects only males due to the design of their reproductive anatomy. It has been said that every man would eventually develop PCa if they simply lived long enough; this is because the disease has a distinctive correlation with aging. PCa is the second leading cause of cancer death for men in the US. The American Cancer Society estimates about 180,890 new cases of PCa in the US for 2016, and 26,120